IP Verse

Orally Administered Corticosteroid Compositions

PatentPatent Analysis

EP2482822

ADARE I
Application Number
EP10821232A
Filing Date
Sep 30, 2010
Status
Revoked
Jul 29, 2022
Grant Date
Aug 1, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3041476B2
EP3403654B1

Bibliography

The patent EP2482822B1 was granted to Adare I on Aug 1, 2018 following the initial filing on Sep 30, 2010 under the application number EP10821232A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DR FALK PHARMAMar 1, 2019ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents